{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T15:47:39Z","timestamp":1789660059215,"version":"4.0.1"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotoxicology and Teratology"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.ntt.2023.107173","type":"journal-article","created":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T20:33:41Z","timestamp":1678221221000},"page":"107173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Discontinuation of methylphenidate after long-term exposure in nonhuman primates"],"prefix":"10.1016","volume":"97","author":[{"given":"X.","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.S.","family":"Berridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.M.","family":"Apana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"W.","family":"Slikker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.G.","family":"Paule","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Talpos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ntt.2023.107173_bb0005","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/jcbfm.1989.117","article-title":"3-(2\u2019-[18F]fluoroethyl)spiperone: in vivo biochemical and kinetic characterization in rodents, nonhuman primates, and humans","volume":"9","author":"Barrio","year":"1989","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.ntt.2023.107173_bb0010","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/toxsci\/kfv007","article-title":"Oral methylphenidate alleviates the fine motor dysfunction caused by chronic postnatal manganese exposure in adult rats","volume":"144","author":"Beaudin","year":"2015","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.ntt.2023.107173_bb0015","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.neuint.2013.12.003","article-title":"The vesicular monoamine transporter 2: an underexplored pharmacological target","volume":"73","author":"Bernstein","year":"2014","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ntt.2023.107173_bb0020","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/jlcr.1672","article-title":"Teflon radiolysis as the major source of carrier in fluorine-18","volume":"52","author":"Berridge","year":"2009","journal-title":"J. Label. Comp. Radiopharmaceut. Off. J. Int. Isotope Soc."},{"key":"10.1016\/j.ntt.2023.107173_bb0025","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1109\/TRPMS.2021.3088606","article-title":"Optimized methodology for reference region and image-derived input function kinetic modeling in preclinical PET","volume":"6","author":"Bini","year":"2021","journal-title":"IEEE Trans. Radiat. Plasma Med. Sci."},{"key":"10.1016\/j.ntt.2023.107173_bb0030","article-title":"18F-FDG-PET detects drastic changes in brain metabolism in the Tg4\u201342 model of Alzheimer\u2019s disease","volume":"425","author":"Bouter","year":"2019","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.ntt.2023.107173_bb0035","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1001\/jama.1971.03190160088021","article-title":"Acetaminophen-induced hepatic necrosis and renal failure","volume":"218","author":"Boyer","year":"1971","journal-title":"JAMA."},{"key":"10.1016\/j.ntt.2023.107173_bb0040","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1124\/jpet.116.235838","article-title":"Effects of ketamine and ketamine metabolites on evoked striatal dopamine release, dopamine receptors, and monoamine transporters","volume":"359","author":"Can","year":"2016","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ntt.2023.107173_bb0045","first-page":"1476","article-title":"Synthesis of high specific activity [18F]-fluoroethyl-tosylate,-spiperone, and-diprenorphine","volume":"52","author":"Carpenter","year":"2011","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ntt.2023.107173_bb0050","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00228-012-1390-7","article-title":"Treatment discontinuation with methylphenidate in adults with attention deficit hyperactivity disorder: a meta-analysis of randomized clinical trials","volume":"69","author":"Castells","year":"2013","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.ntt.2023.107173_bb0055","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1124\/jpet.111.189225","article-title":"Methylphenidate modifies overflow and presynaptic compartmentalization of dopamine via an \u03b1-synuclein-dependent mechanism","volume":"341","author":"Chadchankar","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ntt.2023.107173_bb0060","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.biopsych.2019.04.009","article-title":"Risks and benefits of ADHD medication on behavioral and neuropsychiatric outcomes: a qualitative review of pharmacoepidemiology studies using linked prescription databases","volume":"86","author":"Chang","year":"2019","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ntt.2023.107173_bb0065","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1192\/bjp.2020.129","article-title":"Methylphenidate and mortality in children with attention-deficit hyperactivity disorder: population-based cohort study","volume":"220","author":"Chen","year":"2022","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.ntt.2023.107173_bb0070","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0024-3205(87)90255-4","article-title":"3-N-(2-[18F]-fluoroethyl)-spiperone: a novel ligand for cerebral dopamine receptor studies with pet","volume":"40","author":"Coenen","year":"1987","journal-title":"Life Sci."},{"key":"10.1016\/j.ntt.2023.107173_bb0075","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/BF00253446","article-title":"PET measurement of D2 and S2 receptor binding of 3-N-([2\u2032-18F] fluoroethyl) spiperone in baboon brain","volume":"14","author":"Coenen","year":"1988","journal-title":"Eur. J. Nucl. Med."},{"key":"10.1016\/j.ntt.2023.107173_bb0080","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1056\/NEJMra1917069","article-title":"Pharmacologic treatment of attention deficit\u2013hyperactivity disorder","volume":"383","author":"Cortese","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ntt.2023.107173_bb0085","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S2215-0366(18)30269-4","article-title":"Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis","volume":"5","author":"Cortese","year":"2018","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.ntt.2023.107173_bb0090","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4103\/0973-1229.87261","article-title":"Drug therapy of attention deficit hyperactivity disorder: current trends","volume":"10","author":"De Sousa","year":"2012","journal-title":"Mens Sana Monogr."},{"key":"10.1016\/j.ntt.2023.107173_bb0095","article-title":"Genetics of attention deficit hyperactivity disorder","volume":"1","author":"Faraone","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.ntt.2023.107173_bb0100","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.clinthera.2008.05.006","article-title":"Evolution of the treatment of attention-deficit\/hyperactivity disorder in children: a review","volume":"30","author":"Findling","year":"2008","journal-title":"Clin. Ther."},{"key":"10.1016\/j.ntt.2023.107173_bb0105","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1124\/pr.114.010397","article-title":"Regulation of the dopamine and vesicular monoamine transporters: pharmacological targets and implications for disease","volume":"67","author":"German","year":"2015","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ntt.2023.107173_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0240228","article-title":"Comparative test-retest variability of outcome parameters derived from brain [18F] FDG PET studies in non-human primates","volume":"15","author":"Goutal","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.ntt.2023.107173_bb0115","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.nucmedbio.2014.07.003","article-title":"Comparison of methods for evaluating radiolabelled Annexin A5 uptake in pre-clinical PET oncological studies","volume":"41","author":"Grafstr\u00f6m","year":"2014","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.ntt.2023.107173_bb0120","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.bcp.2007.08.003","article-title":"Monoamine transporters and psychostimulant addiction","volume":"75","author":"Howell","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ntt.2023.107173_bb0125","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/jcbfm.1989.119","article-title":"A double-injection technique for in vivo measurement of dopamine D2-receptor density in monkeys with 3-(2\u2019-[18F]fluoroethyl)spiperone and dynamic positron emission tomography","volume":"9","author":"Huang","year":"1989","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.ntt.2023.107173_bb0130","doi-asserted-by":"crossref","first-page":"E728","DOI":"10.1208\/aapsj070373","article-title":"Regulation of monoamine transporters: influence of psychostimulants and therapeutic antidepressants","volume":"7","author":"Jayanthi","year":"2005","journal-title":"AAPS J."},{"key":"10.1016\/j.ntt.2023.107173_bb0135","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0969-8051(97)00101-7","article-title":"In vivo radiotracers for vesicular neurotransmitter transporters","volume":"24","author":"Kilbourn","year":"1997","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.ntt.2023.107173_bb0140","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.pbb.2008.03.032","article-title":"Relationship between rate of drug uptake in brain and behavioral pharmacology of monoamine transporter inhibitors in rhesus monkeys","volume":"90","author":"Kimmel","year":"2008","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ntt.2023.107173_bb0145","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.nucmedbio.2006.12.005","article-title":"Characterization of optically resolved 9-fluoropropyl-dihydrotetrabenazine as a potential PET imaging agent targeting vesicular monoamine transporters","volume":"34","author":"Kung","year":"2007","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.ntt.2023.107173_bb0150","first-page":"1624","article-title":"Effects of methylphenidate discontinuation on cerebral blood flow in prepubescent boys with attention deficit hyperactivity disorder","volume":"43","author":"Langleben","year":"2002","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ntt.2023.107173_bb0155","series-title":"Molecular Imaging and Contrast Agent Database (MICAD)[Internet]. Vol., ed.^eds","article-title":"3-N-[11C] Methylspiperone","author":"Leung","year":"2011"},{"key":"10.1016\/j.ntt.2023.107173_bb0160","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2967\/jnumed.113.121897","article-title":"In vivo detection of monoaminergic degeneration in early Parkinson disease by (18) F-9-fluoropropyl-(+)-dihydrotetrabenzazine PET","volume":"55","author":"Lin","year":"2014","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ntt.2023.107173_bb0165","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S0969-8051(03)00114-8","article-title":"A review of graphical methods for tracer studies and strategies to reduce bias","volume":"30","author":"Logan","year":"2003","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.ntt.2023.107173_bb0170","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1097\/00004647-199609000-00008","article-title":"Distribution volume ratios without blood sampling from graphical analysis of PET data","volume":"16","author":"Logan","year":"1996","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.ntt.2023.107173_bb0175","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1021\/acschemneuro.5b00010","article-title":"Increased vesicular monoamine transporter 2 (VMAT2; Slc18a2) protects against methamphetamine toxicity","volume":"6","author":"Lohr","year":"2015","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ntt.2023.107173_bb0180","doi-asserted-by":"crossref","first-page":"418","DOI":"10.3389\/fpsyt.2021.642798","article-title":"Intentional discontinuation of psychostimulants used to treat ADHD in youth: a review and analysis","volume":"12","author":"Lohr","year":"2021","journal-title":"Front. Psychiatry."},{"key":"10.1016\/j.ntt.2023.107173_bb0185","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.neuroimage.2007.09.029","article-title":"Effects of neonatal amygdala or hippocampus lesions on resting brain metabolism in the macaque monkey: a microPET imaging study","volume":"39","author":"Machado","year":"2008","journal-title":"Neuroimage."},{"key":"10.1016\/j.ntt.2023.107173_bb0190","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1016\/j.neubiorev.2011.02.011","article-title":"Neurobehavioral adaptations to methylphenidate: the issue of early adolescent exposure","volume":"35","author":"Marco","year":"2011","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ntt.2023.107173_bb0195","doi-asserted-by":"crossref","first-page":"16301","DOI":"10.1073\/pnas.1102187108","article-title":"Pubertal delay in male nonhuman primates (Macaca mulatta) treated with methylphenidate","volume":"108","author":"Mattison","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ntt.2023.107173_bb0200","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s11307-010-0380-3","article-title":"Isoflurane anaesthesia differentially affects the amphetamine sensitivity of agonist and antagonist D2\/D3 positron emission tomography radiotracers: implications for in vivo imaging of dopamine release","volume":"13","author":"McCormick","year":"2011","journal-title":"Mol. Imaging Biol."},{"key":"10.1016\/j.ntt.2023.107173_bb0205","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0031-3955(05)70157-7","article-title":"What is attention-deficit\/hyperactivity disorder?","volume":"46","author":"Mercugliano","year":"1999","journal-title":"Pediatr. Clin. N. Am."},{"key":"10.1016\/j.ntt.2023.107173_bb0210","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1006\/nimg.2002.1239","article-title":"In vivo serotonin 5HT2A receptor binding and personality traits in healthy subjects: a positron emission tomography study","volume":"17","author":"Moresco","year":"2002","journal-title":"Neuroimage."},{"key":"10.1016\/j.ntt.2023.107173_bb0215","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.mrgentox.2008.12.001","article-title":"The genetic toxicology of methylphenidate hydrochloride in non-human primates","volume":"673","author":"Morris","year":"2009","journal-title":"Mutat. Res."},{"key":"10.1016\/j.ntt.2023.107173_bb0220","doi-asserted-by":"crossref","first-page":"6627","DOI":"10.1088\/0031-9155\/52\/22\/005","article-title":"High-resolution imaging of the large non-human primate brain using microPET: a feasibility study","volume":"52","author":"Naidoo-Variawa","year":"2007","journal-title":"Phys. Med. Biol."},{"key":"10.1016\/j.ntt.2023.107173_bb0225","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1523\/JNEUROSCI.16-13-04135.1996","article-title":"Ultrastructural localization of the vesicular monoamine transporter-2 in midbrain dopaminergic neurons: potential sites for somatodendritic storage and release of dopamine","volume":"16","author":"Nirenberg","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ntt.2023.107173_bb0230","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2967\/jnumed.109.070094","article-title":"In vivo measurement of vesicular monoamine transporter type 2 density in Parkinson disease with 18F-AV-133","volume":"51","author":"Okamura","year":"2010","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ntt.2023.107173_bb0235","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1111\/bcp.13544","article-title":"Patterns and profiles of methylphenidate use both in children and adults","volume":"84","author":"Pauly","year":"2018","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ntt.2023.107173_bb0245","series-title":"Is there long-Term Benefit from Stimulant Treatment for ADHD?, Vol. 176, ed.^eds","first-page":"685","author":"Pliszka","year":"2019"},{"key":"10.1016\/j.ntt.2023.107173_bb0250","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.neuro.2003.10.007","article-title":"Neuroimaging: new approaches for neurotoxicology","volume":"25","author":"Pogge","year":"2004","journal-title":"Neurotoxicology."},{"key":"10.1016\/j.ntt.2023.107173_bb0255","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ntt.2009.08.011","article-title":"The effects of chronic methylphenidate administration on operant test battery performance in juvenile rhesus monkeys","volume":"32","author":"Rodriguez","year":"2010","journal-title":"Neurotoxicol. Teratol."},{"key":"10.1016\/j.ntt.2023.107173_bb0260","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0166-4328(01)00425-9","article-title":"Hypodopaminergic and hypernoradrenergic activity in prefrontal cortex slices of an animal model for attention-deficit hyperactivity disorder--the spontaneously hypertensive rat","volume":"130","author":"Russell","year":"2002","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ntt.2023.107173_bb0265","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/c76da2c1-ccb8-4797-94c1-359d3ceceeda","article-title":"Methylphenidate exposure induces dopamine neuron loss and activation of microglia in the basal ganglia of mice","volume":"7","author":"Sadasivan","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ntt.2023.107173_bib391","series-title":"A combined MRI and histology atlas of the rhesus monkey brain in stereotaxic coordinates","author":"Saleem","year":"2012"},{"key":"10.1016\/j.ntt.2023.107173_bb0270","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/0883-2897(86)90035-8","article-title":"No-carrier-added 3-(2\u2019-[18F]fluoroethyl)spiperone, a new dopamine receptor-binding tracer for positron emission tomography","volume":"13","author":"Satyamurthy","year":"1986","journal-title":"Int. J. Rad. Appl. Instrum. B."},{"key":"10.1016\/j.ntt.2023.107173_bb0275","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S2215-0366(17)30167-0","article-title":"ADHD in children and young people: prevalence, care pathways, and service provision","volume":"5","author":"Sayal","year":"2018","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.ntt.2023.107173_bb0280","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1744-6171.2004.00085.x","article-title":"Methylphenidate: Mechanism of action and clinical update","volume":"17","author":"Scahill","year":"2004","journal-title":"J. Child Adolescent Psychiatric Nurs."},{"key":"10.1016\/j.ntt.2023.107173_bb0285","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.lfs.2008.09.019","article-title":"Methylphenidate increases creatine kinase activity in the brain of young and adult rats","volume":"83","author":"Scaini","year":"2008","journal-title":"Life Sci."},{"key":"10.1016\/j.ntt.2023.107173_bb0290","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0006-8993(02)04167-7","article-title":"Decreased limbic vesicular monoamine transporter 2 in a genetic rat model of depression","volume":"965","author":"Schwartz","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.ntt.2023.107173_bb0295","first-page":"2083","article-title":"Effects of statistical noise on graphic analysis of PET neuroreceptor studies","volume":"41","author":"Slifstein","year":"2000","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ntt.2023.107173_bb0300","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0969-8051(01)00214-1","article-title":"Models and methods for derivation of in vivo neuroreceptor parameters with PET and SPECT reversible radiotracers","volume":"28","author":"Slifstein","year":"2001","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.ntt.2023.107173_bb0305","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.neuro.2003.09.011","article-title":"Neuroimaging: strategies to illuminate environment-disease linkages. Session II. Summary and research needs","volume":"25","author":"Slikker","year":"2004","journal-title":"Neurotoxicology."},{"key":"10.1016\/j.ntt.2023.107173_bb0310","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s10488-019-00983-6","article-title":"A prescription trend analysis of methylphenidate: Relation to study reports on efficacy","volume":"47","author":"Sluiter","year":"2020","journal-title":"Adm. Policy Ment. Health Ment. Health Serv. Res."},{"key":"10.1016\/j.ntt.2023.107173_bb0315","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1001\/jamapediatrics.2016.1775","article-title":"Association of acetaminophen use during pregnancy with behavioral problems in childhood: evidence against confounding","volume":"170","author":"Stergiakouli","year":"2016","journal-title":"JAMA Pediatr."},{"key":"10.1016\/j.ntt.2023.107173_bb0320","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0893-133X(00)00165-2","article-title":"In vivo measurement of the vesicular monoamine transporter in schizophrenia","volume":"23","author":"Taylor","year":"2000","journal-title":"Neuropsychopharmacology."},{"key":"10.1016\/j.ntt.2023.107173_bb0325","doi-asserted-by":"crossref","first-page":"e994","DOI":"10.1542\/peds.2014-3482","article-title":"Prevalence of attention-deficit\/hyperactivity disorder: a systematic review and meta-analysis","volume":"135","author":"Thomas","year":"2015","journal-title":"Pediatrics."},{"key":"10.1016\/j.ntt.2023.107173_bb0330","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.nucmedbio.2010.01.002","article-title":"Binding characteristics of 9-fluoropropyl-(+)-dihydrotetrabenzazine (AV-133) to the vesicular monoamine transporter type 2 in rats","volume":"37","author":"Tsao","year":"2010","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.ntt.2023.107173_bb0335","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.euroneuro.2011.03.008","article-title":"To stop or not to stop? How long should medication treatment of attention-deficit hyperactivity disorder be extended?","volume":"21","author":"van de Loo-Neus","year":"2011","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.ntt.2023.107173_bb0340","series-title":"The renaissance of functional 18F-FDG PET brain activation imaging","first-page":"2338","volume":"45","author":"Verger","year":"2018"},{"key":"10.1016\/j.ntt.2023.107173_bb0345","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1001\/archneurol.2011.142","article-title":"In vivo assessment of vesicular monoamine transporter type 2 in dementia with lewy bodies and Alzheimer disease","volume":"68","author":"Villemagne","year":"2011","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ntt.2023.107173_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaac.2013.09.001","article-title":"Trends in the parent-report of health care provider-diagnosed and medicated attention-deficit\/hyperactivity disorder: United States, 2003\u20132011","volume":"53","author":"Visser","year":"2014","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.ntt.2023.107173_bb0355","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1177\/070674370200601S05","article-title":"Mechanism of action of methylphenidate: insights from PET imaging studies","volume":"6","author":"Volkow","year":"2002","journal-title":"J. Atten. Disord."},{"key":"10.1016\/j.ntt.2023.107173_bb0360","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/j.biopsych.2004.11.006","article-title":"Imaging the effects of methylphenidate on brain dopamine: new model on its therapeutic actions for attention-deficit\/hyperactivity disorder","volume":"57","author":"Volkow","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ntt.2023.107173_bb0365","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1097\/JCP.0b013e318173312f","article-title":"Effects of methylphenidate on the catecholaminergic system in attention-deficit\/hyperactivity disorder","volume":"28","author":"Wilens","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.ntt.2023.107173_bb0370","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/s41390-018-0256-9","article-title":"A randomized controlled laboratory study on the long-term effects of methylphenidate on cardiovascular function and structure in rhesus monkeys","volume":"85","author":"Wilkinson","year":"2019","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ntt.2023.107173_bb0375","doi-asserted-by":"crossref","first-page":"e181471","DOI":"10.1001\/jamanetworkopen.2018.1471","article-title":"Twenty-year trends in diagnosed attention-deficit\/hyperactivity disorder among US children and adolescents, 1997-2016","volume":"1","author":"Xu","year":"2018","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.ntt.2023.107173_bb0380","series-title":"Comprehensive Toxicology","first-page":"442","article-title":"Molecular imaging: a new frontier in neurotoxicology","volume":"Vol. 6","author":"Zhang","year":"2018"},{"key":"10.1016\/j.ntt.2023.107173_bb0385","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ntt.2016.06.005","article-title":"MicroPET\/CT assessment of FDG uptake in brain after long-term methylphenidate treatment in nonhuman primates","volume":"56","author":"Zhang","year":"2016","journal-title":"Neurotoxicol. Teratol."},{"key":"10.1016\/j.ntt.2023.107173_bb0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.ntt.2021.107017","article-title":"MicroPET\/CT assessment of neurochemical effects in the brain after long-term methylphenidate treatment in nonhuman primates","volume":"87","author":"Zhang","year":"2021","journal-title":"Neurotoxicol. Teratol."}],"container-title":["Neurotoxicology and Teratology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0892036223000235?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0892036223000235?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T19:28:46Z","timestamp":1760210926000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0892036223000235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":78,"alternative-id":["S0892036223000235"],"URL":"https:\/\/doi.org\/10.1016\/j.ntt.2023.107173","relation":{},"ISSN":["0892-0362"],"issn-type":[{"value":"0892-0362","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discontinuation of methylphenidate after long-term exposure in nonhuman primates","name":"articletitle","label":"Article Title"},{"value":"Neurotoxicology and Teratology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ntt.2023.107173","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107173"}}